Literature DB >> 32607771

A rare case of hyporeninemic hypertension: Answers.

Ahmad Mashmoushi1, Abha Choudhary2, Christie P Thomas3, Matthias T F Wolf4,5.   

Abstract

Entities:  

Keywords:  Child; Hyporeninemic hypertension; KCNJ5; Kir3.4; Monogenic; Mutation

Year:  2020        PMID： 32607771      PMCID： PMC7772256          DOI： 10.1007/s00467-020-04667-4

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN： 0931-041X            Impact factor:   3.714


× No keyword cloud information.
  31 in total

1.  Laboratory investigation of primary aldosteronism.

Authors:  Michael Stowasser; Paul J Taylor; Eduardo Pimenta; Ashraf H Al-Asaly Ahmed; Richard D Gordon
Journal:  Clin Biochem Rev       Date:  2010-05

Review 2.  The multifaceted mineralocorticoid receptor.

Authors:  Elise Gomez-Sanchez; Celso E Gomez-Sanchez
Journal:  Compr Physiol       Date:  2014-07       Impact factor: 9.090

3.  Control of cell proliferation in the rat adrenal gland in vivo by the renin-angiotensin system.

Authors:  P E McEwan; G B Lindop; C J Kenyon
Journal:  Am J Physiol       Date:  1996-07

4.  Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy.

Authors:  D S Geller; A Farhi; N Pinkerton; M Fradley; M Moritz; A Spitzer; G Meinke; F T Tsai; P B Sigler; R P Lifton
Journal:  Science       Date:  2000-07-07       Impact factor: 47.728

5.  A case of severe hyperaldosteronism caused by a de novo mutation affecting a critical salt bridge Kir3.4 residue.

Authors:  Silvia Monticone; Sascha Bandulik; Julia Stindl; Mihail Zilbermint; Ivan Dedov; Paolo Mulatero; Michael Allgaeuer; Chyi-Chia Richard Lee; Constantine A Stratakis; Tracy A Williams; Anatoly Tiulpakov
Journal:  J Clin Endocrinol Metab       Date:  2015-01       Impact factor: 5.958

6.  K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension.

Authors:  Murim Choi; Ute I Scholl; Peng Yue; Peyman Björklund; Bixiao Zhao; Carol Nelson-Williams; Weizhen Ji; Yoonsang Cho; Aniruddh Patel; Clara J Men; Elias Lolis; Max V Wisgerhof; David S Geller; Shrikant Mane; Per Hellman; Gunnar Westin; Göran Åkerström; Wenhui Wang; Tobias Carling; Richard P Lifton
Journal:  Science       Date:  2011-02-11       Impact factor: 47.728

7.  A novel form of human mendelian hypertension featuring nonglucocorticoid-remediable aldosteronism.

Authors:  David S Geller; Junhui Zhang; Max V Wisgerhof; Cedric Shackleton; Michael Kashgarian; Richard P Lifton
Journal:  J Clin Endocrinol Metab       Date:  2008-05-27       Impact factor: 5.958

8.  Regulation of the renal NaCl cotransporter by the WNK/SPAK pathway: lessons learned from genetically altered animals.

Authors:  Mauricio Ostrosky-Frid; María Castañeda-Bueno; Gerardo Gamba
Journal:  Am J Physiol Renal Physiol       Date:  2018-08-08

9.  CLCN2 chloride channel mutations in familial hyperaldosteronism type II.

Authors:  Gabriel Stölting; Julia Schewe; Ute I Scholl; Anne Thiel; Hua Tan; Carol Nelson-Williams; Alfred A Vichot; Sheng Chih Jin; Erin Loring; Verena Untiet; Taekyeong Yoo; Jungmin Choi; Shengxin Xu; Aihua Wu; Marieluise Kirchner; Philipp Mertins; Lars C Rump; Ali Mirza Onder; Cory Gamble; Daniel McKenney; Robert W Lash; Deborah P Jones; Gary Chune; Priscila Gagliardi; Murim Choi; Richard Gordon; Michael Stowasser; Christoph Fahlke; Richard P Lifton
Journal:  Nat Genet       Date:  2018-02-05       Impact factor: 38.330

10.  Recurrent gain of function mutation in calcium channel CACNA1H causes early-onset hypertension with primary aldosteronism.

Authors:  Ute I Scholl; Gabriel Stölting; Carol Nelson-Williams; Alfred A Vichot; Murim Choi; Erin Loring; Manju L Prasad; Gerald Goh; Tobias Carling; C Christofer Juhlin; Ivo Quack; Lars C Rump; Anne Thiel; Marc Lande; Britney G Frazier; Majid Rasoulpour; David L Bowlin; Christine B Sethna; Howard Trachtman; Christoph Fahlke; Richard P Lifton
Journal:  Elife       Date:  2015-04-24       Impact factor: 8.713
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.